Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
Although several viruses can easily infect the central nervous system (CNS), antiviral drugs often show dramatic difficulties in penetrating the brain from the bloodstream since they are substrates of active efflux transporters (AETs). These transporters, located in the physiological barriers betwee...
Main Authors: | Alessandro Dalpiaz, Barbara Pavan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/10/2/39 |
Similar Items
-
Characterization of Magnetic Polymeric Microparticles
by: Kazım Köse
Published: (2016-08-01) -
An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
by: Sihem Bouriche, et al.
Published: (2021-09-01) -
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
by: Alessandro Giuliani, et al.
Published: (2018-01-01) -
The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges
by: Alejandra Barrera-Rosales, et al.
Published: (2023-08-01) -
Encapsulation of Inorganic Nanoparticles by Anionic Emulsion Polymerization of Diethyl Methylene Malonate for Developing Hybrid Microparticles with Tailorable Composition
by: Shreyas Joshi, et al.
Published: (2024-02-01)